BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 31217854)

  • 1. FAT4-USP51 complex regulates the proliferation and invasion of endometrial cancer via Hippo pathway.
    Che X; Jian F; Jia N; Zheng Y; Jiang Y; Feng W
    Am J Transl Res; 2019; 11(5):2784-2800. PubMed ID: 31217854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells.
    Ma L; Cui J; Xi H; Bian S; Wei B; Chen L
    Cancer Biol Ther; 2016; 17(1):36-47. PubMed ID: 26575609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.
    Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L
    Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/β-catenin signalling.
    Cai J; Feng D; Hu L; Chen H; Yang G; Cai Q; Gao C; Wei D
    Br J Cancer; 2015 Dec; 113(12):1720-9. PubMed ID: 26633557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WWC3 regulates the Wnt and Hippo pathways via Dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis.
    Han Q; Lin X; Zhang X; Jiang G; Zhang Y; Miao Y; Rong X; Zheng X; Han Y; Han X; Wu J; Kremerskothen J; Wang E
    J Pathol; 2017 Aug; 242(4):435-447. PubMed ID: 28543074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of FAT Atypical Cadherin 4 Expression Is Associated with High Pathologic T Stage in Radically Resected Gastric Cancer.
    Jung HY; Cho H; Oh MH; Lee JH; Lee HJ; Jang SH; Lee MS
    J Gastric Cancer; 2015 Mar; 15(1):39-45. PubMed ID: 25861521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low FAT4 expression is associated with a poor prognosis in gastric cancer patients.
    Jiang X; Liu Z; Xia Y; Luo J; Xu J; He X; Tao H
    Oncotarget; 2018 Jan; 9(4):5137-5154. PubMed ID: 29435168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAT4 functions as a tumor suppressor in triple-negative breast cancer.
    Hou L; Chen M; Zhao X; Li J; Deng S; Hu J; Yang H; Jiang J
    Tumour Biol; 2016 Nov; ():. PubMed ID: 27896700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP51 promotes deubiquitination and stabilization of ZEB1.
    Zhou Z; Zhang P; Hu X; Kim J; Yao F; Xiao Z; Zeng L; Chang L; Sun Y; Ma L
    Am J Cancer Res; 2017; 7(10):2020-2031. PubMed ID: 29119051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function and cancer genomics of FAT family genes (review).
    Katoh M
    Int J Oncol; 2012 Dec; 41(6):1913-8. PubMed ID: 23076869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway.
    Li L; Zhao J; Huang S; Wang Y; Zhu L; Cao Y; Xiong J; Deng J
    Gene; 2018 Jan; 641():240-247. PubMed ID: 29045821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Downregulation of Herg1 suppresses osteosarcoma proliferation and invasion by targeting Hippo signaling pathway].
    Chen ZD; Ye WB; Zeng WR; Song C; Song W; Zhang YM; Wu J
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):338-345. PubMed ID: 31137166
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
    Wang Y; Dong L; Liu Y
    Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
    [No Abstract]   [Full Text] [Related]  

  • 15. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
    Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
    J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coiled-coil domain of oncogene RASSF 7 inhibits hippo signaling and promotes non-small cell lung cancer.
    Zheng X; Dong Q; Zhang X; Han Q; Han X; Han Y; Wu J; Rong X; Wang E
    Oncotarget; 2017 Oct; 8(45):78734-78748. PubMed ID: 29108261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor-associated kinase 1 correlates with metastasis and invasion in endometrial carcinoma.
    Wang Y; Wang Y; Duan X; Wang Y; Zhang Z
    J Cell Biochem; 2018 Mar; 119(3):2545-2555. PubMed ID: 28980703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of miR-184 restrains the growth and invasion of endometrial carcinoma cells through CDC25A-dependent Notch signaling pathway.
    Chen Z; Zhu Y; Fan X; Liu Y; Feng Q
    Am J Transl Res; 2019; 11(2):755-764. PubMed ID: 30899377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response.
    Wang Z; Zhang H; Liu J; Cheruiyot A; Lee JH; Ordog T; Lou Z; You Z; Zhang Z
    Genes Dev; 2016 Apr; 30(8):946-59. PubMed ID: 27083998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinic-pathological significances of HOXB8, ILK and FAT4 expression in colorectal cancer.
    Abuderman AA; Harb OA; Gertallah LM
    Contemp Oncol (Pozn); 2020; 24(3):183-192. PubMed ID: 33235545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.